⚡ Quick Answer
What is the NEC baby formula lawsuit? Parents of premature infants are suing Mead Johnson (Enfamil) and Abbott Laboratories (Similac), alleging these manufacturers knew cow's milk-based formulas significantly increased the risk of necrotizing enterocolitis (NEC) in preterm infants but failed to warn hospitals and parents. NEC is a severe gastrointestinal disease that can cause bowel perforation, sepsis, lifelong disability, and death. As of April 2026, 782 cases are active in a federal MDL and state courts are accelerating with active verdicts and upcoming trials. State court juries have returned verdicts totaling over $625 million to date. No global settlement has been reached in the federal MDL.
Who Qualifies for an NEC Baby Formula Lawsuit
Eligibility focuses on premature or very low birth weight infants who developed NEC after receiving Enfamil or Similac — in the NICU, at home, or both. Parents and legal guardians may file on behalf of their child, including in cases of wrongful death.
Qualifying Criteria:
How Formula Manufacturers Caused Harm
Lawsuits allege that Mead Johnson and Abbott Laboratories knew — or should have known — that cow's milk-based formula dramatically increased the risk of NEC in premature infants, yet failed to adequately warn hospitals and parents. Four core patterns of alleged misconduct appear across active cases:
1. Failure to Warn About NEC Risk in Preterm Infants
Peer-reviewed research has long linked cow's milk-based formula to elevated NEC rates in premature infants compared to human milk. Lawsuits allege manufacturers had access to this science and failed to include adequate warnings on product labels and in materials provided to NICUs and caregivers.
2. Marketing Cow's Milk Formula for Vulnerable Preterm Infants
Enfamil and Similac were heavily marketed for use in NICUs — including for the most vulnerable, extremely premature infants — without clear guidance about the significantly elevated NEC risk that cow's milk proteins pose to developing preterm digestive systems.
3. Inadequate Guidance to Hospitals and Caregivers
Lawsuits allege manufacturers failed to provide sufficient clinical guidance to NICU staff about when cow's milk formula should be avoided or used with caution in preterm infants. The American Academy of Pediatrics has long recommended prioritizing human milk for premature infants — guidance manufacturers allegedly did not reinforce.
4. Prioritizing Market Share Over Infant Safety
Complaints allege both Mead Johnson and Abbott Laboratories prioritized NICU market penetration and commercial relationships over the safety of the most vulnerable neonatal patients — premature infants whose digestive systems are not equipped to safely process cow's milk proteins.
NEC Injuries & Complications Recognized in Active Claims
The strongest cases involve serious, documented NEC complications directly tied to formula use in the NICU. Courts consider both economic and non-economic damages when evaluating claims.
NEC Lawsuit Settlement Factors & Ranges
No global settlement has been reached in the federal MDL. State court juries have returned verdicts totaling over $625 million — including a $495 million verdict against Abbott (Missouri, July 2024), a $60 million verdict against Mead Johnson (Illinois, March 2024), and a $70 million verdict against Abbott (Cook County, April 2026). When individual cases resolve, compensation depends on several key factors:
- 🔴
Medical severity — bowel surgery, ostomy, perforation, sepsis, or permanent disability typically yield higher compensation
- 🔴
NICU length of stay — prolonged hospitalization and intensive care costs significantly increase claim value
- 📋
Documentation strength — NICU records, feeding logs, operative reports, pathology, and imaging are essential to claim strength
- 📅
Long-term outcomes — short bowel syndrome, neurological damage, or growth failure significantly strengthen claims
- ⚖️
Venue and jury trends — state courts in Missouri, Illinois, and California have produced major plaintiff verdicts; the federal MDL has been more challenging for plaintiffs on expert testimony grounds
- 💀
Wrongful death — cases involving infant death carry the highest potential values, ranging from $1M to $5M+ depending on jurisdiction
$70 million — Abbott Laboratories (Similac Special Care 24), Cook County, Illinois, April 2026 — $53M compensatory + $17M punitive; four families; Abbott appealing
$495 million — Abbott Laboratories (Similac), Missouri state court, July 2024 — $95M compensatory + $400M punitive
$60 million — Mead Johnson (Enfamil), Illinois state court, March 2024
Defense verdict — Joint Abbott/Mead Johnson trial, Missouri state court, October 2024 — overturned; retrial ordered
Illustrative Individual Settlement Ranges:
NEC with conservative care: $50,000 – $250,000+
NEC with surgery: $250,000 – $1M+
Long-term disability: $500,000 – $2M+
Wrongful death: $1M – $5M+
Disclaimer: No global settlement has been reached in the federal MDL. Ranges are based on litigation patterns and verdict reports and are educational only — not a guarantee of outcome. Actual results depend on case-specific facts, venue, and litigation developments.
Deadlines for Filing an NEC Lawsuit (State-by-State)
Each state has strict statutes of limitations for product liability and personal injury claims — typically 2 to 3 years. For claims involving minors, many states toll (pause) the deadline until the child turns 18, then add additional years. Missing your deadline permanently bars your claim.
| State | Standard SOL | Minor Tolling | Notes |
|---|---|---|---|
| Illinois | 2 years | Yes | $60M plaintiff verdict (March 2024); $70M Cook County verdict against Abbott (April 2026) — Abbott appealing; Illinois First District Appellate Court ruled Cook County is only proper venue for Illinois-resident cases — non-IL cases shifting to Madison County and other jurisdictions |
| Missouri | 5 years | Yes | $495M verdict against Abbott (July 2024); October 2024 defense verdict overturned by judge for defense misconduct — retrial ordered; strong plaintiff venue with longest SOL |
| California | 2 years | Yes | Active state court filings increasing in 2025–2026; 7th Circuit skeptical of keeping some claims in federal court (March 2026), which may further accelerate state filings |
| New York | 3 years | Yes | Longer standard SOL; individual state filings active |
| Texas | 2 years | Yes | Wrongful death claims must be filed within 2 years of the infant's death |
| Florida | 2 years | Yes | SOL recently shortened; consult an attorney immediately if your child's diagnosis occurred years ago |
| Louisiana | 1 year | Yes | Shortest SOL in the nation — act immediately |
| All Other States | Typically 2–3 years | Varies | Many states extend deadlines for minors. Do not assume it is too late — consult an attorney immediately to confirm your deadline. |
Discovery rules and minor tolling provisions can significantly extend filing windows. Do not assume it is too late without speaking to an attorney.
NEC Baby Formula Lawsuit Updates — 2026
Last updated April 2026. We update this section monthly with new case filings, MDL developments, and notable rulings.
-
April 9–10, 2026 🔴 Verdict$70 Million Verdict in Cook County Similac Trial — Abbott to Appeal: A Cook County, Illinois jury returned a $70 million verdict against Abbott Laboratories on April 9–10, 2026 — awarding $53 million in compensatory damages and $17 million in punitive damages to four families whose premature infants developed NEC after being fed Similac Special Care 24 formula in Chicago-area NICUs between 2012 and 2019. All four children survived but required surgery and live with ongoing health problems. The case was tried by Keller Postman, who called the verdict proof that "Abbott has known for years and chosen to ignore" that its formula causes NEC in premature infants. Abbott said it would appeal, calling the verdict "out of step with the overwhelming consensus of the medical community and regulators." This is the second state court plaintiff verdict in Illinois, following the 2024 $60 million Mead Johnson verdict, and brings total state court verdicts to over $625 million. The federal MDL's first second-wave bellwether trial is still set for July 6, 2026.
-
April 2026 🔴 NewCook County State Court NEC Trial Begins — Second Wave of Federal Bellwethers Scheduled: A new state court NEC trial began in Cook County, Illinois in April 2026 — four families alleging Abbott's Similac Special Care 24 caused NEC in their premature infants born at Chicago-area hospitals between 2012 and 2019. The trial concluded with a $70 million plaintiff verdict on April 9–10 (see above). Meanwhile, the court overseeing the federal MDL ordered both sides to submit a revised case management schedule by April 16, 2026, signaling a push toward structured resolution. A second wave of federal bellwether trials is now formally scheduled: July 6, 2026; August 2026; November 2026; and February 2027 — all naming Abbott as the sole defendant and focusing on severe NEC injuries and wrongful death claims linked to Similac products.
-
April 2026 🔴 NewMDL Grows to 782 Cases — 7th Circuit Skeptical of Federal Retention: The NEC baby formula federal MDL has grown to 782 pending cases as of April 2026. In a significant development, the 7th U.S. Circuit Court of Appeals indicated skepticism about keeping certain NEC claims in federal court (March 1, 2026 hearing), which legal observers expect will further accelerate the shift of new filings to plaintiff-friendly state courts in Missouri, Illinois, and California. The court's stance reinforces what has become the dominant litigation strategy: pursue the federal MDL on a parallel track while concentrating new and strongest cases in state court.
-
April 2026 🔴 NewMissouri Defense Verdict Overturned — Retrial Ordered for Defense Misconduct: A Missouri judge overturned the October 2024 defense verdict — the only win Abbott and Mead Johnson had secured in state court — after finding misconduct by defense counsel. A retrial has been ordered. This removes the one data point that had briefly suggested defendants could win in front of state juries and further strengthens the plaintiff litigation posture going into the 2026 trial schedule.
-
March 2026State Court Strategy Accelerates as Federal MDL Stalls: Abbott has now won summary judgment in three consecutive federal bellwether trials — largely because federal courts apply stricter Daubert expert testimony standards that have excluded key plaintiff experts. In response, plaintiffs' attorneys are increasingly filing new NEC claims directly in state courts, particularly in Missouri, Illinois, and California, where evidentiary standards are more permissive and juries have already returned major plaintiff verdicts.
-
March 2026 — Cook County Venue RulingIllinois Appellate Court Limits Cook County as NEC Venue: The Illinois First District Appellate Court ruled that Cook County is not the proper venue for NEC cases involving infants born, treated, and injured entirely outside Illinois. Only cases involving Illinois residents may remain in Cook County. The decision shifts some Illinois state court activity to Madison County and other jurisdictions, but does not affect the hundreds of NEC cases already pending there or in the federal MDL.
-
February 15, 2026Pediatric Research Publishes New NEC-Formula Analysis: A peer-reviewed article in Pediatric Research reviews the legal, clinical, and scientific debates over formula use and NEC in preterm infants. The authors — broadly sympathetic to defendants — acknowledge that juries continue siding with plaintiffs and that the litigation is actively changing hospital feeding protocols nationwide, with more NICUs now prioritizing donor breast milk for preterm infants.
-
February 2, 2026Bellwether Trial Reset to July 6, 2026; JPML Keeps Case in MDL: The Inman v. Mead Johnson & Company bellwether trial — originally scheduled for February 2 — is reset to July 6, 2026, following pretrial procedural rulings. Separately, the Judicial Panel on Multidistrict Litigation refuses to remand a related California case back to state court, keeping it within the federal MDL.
-
January 9, 2026Alabama Wrongful Death Lawsuit Filed: A new complaint is filed in Alabama alleging that a baby born at 30 weeks' gestation developed NEC after receiving cow's milk-based formula and died at approximately ten days old. As of January 2026, the MDL holds approximately 769 pending cases with roughly 950 total historical filings, as plaintiffs' attorneys increasingly route new claims to state courts in Missouri, Illinois, and California where juries have already awarded major verdicts.
-
December 2025MDL Adds 19 New Cases; Judge Orders Comprehensive Plaintiff Census: The NEC baby formula MDL gains 19 new cases in November, bringing total pending federal lawsuits to 774. Judge Pallmeyer also issues Case Management Order No. 14, requiring plaintiffs' attorneys to submit detailed census information for every filed, unfiled, and state court NEC claim — a signal that the court is pushing toward a structured path to resolution.
-
October 2025Third Federal Bellwether Dismissed — Abbott Wins Summary Judgment Again: U.S. District Judge Pallmeyer grants summary judgment in favor of Abbott in the third consecutive federal MDL bellwether trial, ruling that the plaintiff's expert witness testimony failed to adequately link the infant's NEC diagnosis to formula use under the federal Daubert standard. This marks Abbott's third straight federal win. No federal MDL case has reached a jury. The ruling accelerates the shift of new filings to state courts.
-
October 2024Defense Verdict in Missouri — Later Overturned for Misconduct: A St. Louis jury sides with Abbott and Mead Johnson in the third state court NEC trial — the first defense verdict in the litigation. However, the judge subsequently overturned the verdict and ordered a retrial after finding defense counsel misconduct, removing this as a meaningful defense win and restoring the plaintiff-favorable state court record.
-
July 2024$495 Million Verdict Against Abbott — Landmark State Court Win: A St. Louis jury awards $95 million in compensatory damages and $400 million in punitive damages to the family of a child who developed NEC and suffered permanent neurological damage after being fed Similac in the NICU. The $495 million total — secured by TorHoerman Law as lead trial counsel — is the largest verdict in the NEC litigation and set a powerful precedent for future plaintiff claims.
-
March 2024$60 Million Verdict Against Mead Johnson (Enfamil) in Illinois: A St. Clair County, Illinois jury awards $60 million to the family of an infant who died from NEC after being fed Mead Johnson's Enfamil formula in the NICU. This was the first successful NEC trial verdict anywhere in the country and set a critical precedent for subsequent state court cases.
-
2021–2022Initial Federal Filings; MDL Established: The first NEC baby formula lawsuits are filed against Mead Johnson and Abbott Laboratories. Cases expand rapidly in federal and state courts as families come forward with NEC diagnoses linked to NICU formula use. The Judicial Panel on Multidistrict Litigation consolidates federal cases into MDL No. 3026 in the Northern District of Illinois before Judge Rebecca Pallmeyer.
Find Out If Your Family Qualifies — Free Case Review
Attorneys are reviewing NEC baby formula cases nationwide — including state court filings in Missouri, Illinois, and California. You pay nothing unless compensation is recovered.
Start My Free Case ReviewHow the NEC Baby Formula Lawsuit Process Works
Attorneys accept NEC baby formula cases on contingency — you pay nothing unless compensation is recovered.
- Free confidential consultation — Share your child's NICU history, formula use, and NEC diagnosis with an attorney at no cost. No records are required before reaching out.
- Case review and evidence gathering — Your attorney reviews NICU records, feeding logs, operative reports, pathology, and all evidence of harm. Your attorney can assist in obtaining records you don't yet have.
- Identifying the products — Your attorney confirms which formula products were used and whether those products are subject to active litigation in state court or federal MDL proceedings.
- Determining the legal pathway — Given that Abbott has won three consecutive federal MDL bellwether trials on expert testimony grounds, your attorney will evaluate whether state court (Missouri, Illinois, California) or the federal MDL is the stronger venue for your specific case. The April 2026 $70 million Cook County verdict confirms state courts remain a powerful venue for plaintiffs. Claims are typically brought under product liability (failure to warn, defective design) and negligence theories.
- Filing the lawsuit — Your attorney files suit in the appropriate court. State court filings in plaintiff-friendly jurisdictions are increasing; the federal MDL continues to coordinate hundreds of additional cases.
- Discovery — Both sides exchange evidence: manufacturer internal documents, formula testing records, communications about known NEC risks, and marketing materials directed at NICUs and hospitals.
- Expert testimony — Neonatologists, gastroenterologists, pathologists, and formula design experts testify about NEC causation and the adequacy of manufacturer warnings. Expert qualification is particularly important given federal Daubert challenges that have dismissed three MDL bellwether cases.
- Settlement or trial — Cases may settle through negotiation or proceed to trial. State court juries have awarded $625M+ to date, including a $70 million Cook County verdict in April 2026. Federal MDL bellwether trials begin July 6, 2026. Attorneys continue to pursue the best possible outcome for each family.
Frequently Asked Questions
What is NEC and why are families filing lawsuits?
Necrotizing enterocolitis (NEC) is a life-threatening gastrointestinal disease most common in premature infants. It can cause bowel tissue to die, leading to perforation, sepsis, and death. Multiple peer-reviewed studies report significantly higher NEC rates in preemies fed cow's milk-based formula compared with human milk.
Lawsuits allege that Mead Johnson (Enfamil) and Abbott Laboratories (Similac) knew about this risk and failed to adequately warn hospitals and parents — placing profits over the safety of vulnerable premature infants. State court juries have already awarded over $625 million to plaintiffs, including a $70 million Cook County verdict in April 2026.
Who qualifies for an NEC baby formula lawsuit?
Typically: a premature or very low birth-weight infant who received Enfamil or Similac in the NICU and/or at home, with a confirmed NEC diagnosis and resulting surgery, long-term complications, or wrongful death.
Mixed feeding (both breast milk and formula) does not automatically disqualify a claim. Eligibility depends on timing, duration, and clinical course, evaluated by attorneys and medical experts.
What evidence should we gather for an NEC lawsuit?
The most valuable records are NICU notes, feeding and formula logs, medication records, operative reports, pathology results, imaging, discharge summaries, and pediatric follow-up notes. At-home feeding documentation is also helpful.
You do not need all records in hand before reaching out. Your attorney can help identify what is needed and assist in obtaining records from the hospital and NICU.
Do I sue the hospital, the manufacturer, or both?
Most NEC lawsuits focus on product manufacturers — Mead Johnson (Enfamil) and Abbott Laboratories (Similac) — under failure-to-warn and product liability theories. Whether the hospital may also be a defendant depends on your specific facts and state law. An attorney can evaluate all potential defendants based on your situation.
How much are NEC baby formula lawsuit settlements worth?
No global settlement has been reached in the federal MDL. State court juries have awarded over $625 million to date, including a $495 million verdict against Abbott (Missouri, July 2024), a $60 million verdict against Mead Johnson (Illinois, March 2024), and a $70 million verdict against Abbott (Cook County, April 2026 — Abbott appealing). The Missouri defense verdict was subsequently overturned for misconduct and a retrial ordered. Illustrative individual ranges: NEC with conservative care ($50,000–$250,000+); NEC with surgery ($250,000–$1M+); long-term disability ($500,000–$2M+); wrongful death ($1M–$5M+).
These ranges are educational only and not a guarantee of outcome. Actual results depend on medical severity, documentation, venue, jury trends, and case-specific facts.
What if my child received both breast milk and formula?
Mixed feeding does not automatically disqualify your claim. Eligibility depends on the timing and duration of formula use relative to the NEC diagnosis, reviewed by attorneys and medical experts on a case-by-case basis.
How long do I have to file an NEC lawsuit?
Deadlines vary by state and claim type, typically 1 to 3 years for product liability. Many states toll (pause) the deadline until the child turns 18, then add additional years. Wrongful death deadlines differ from personal injury deadlines.
Missing your deadline permanently bars your claim. Speak to an attorney immediately — do not assume it is too late without confirming your state's specific rules.
Has there been an NEC class action settlement?
No global class action settlement has been finalized. A Cook County jury awarded $70 million against Abbott on April 9–10, 2026 — the second state court plaintiff verdict in Illinois — with Abbott stating it will appeal. Abbott has won summary judgment in three straight federal MDL bellwether trials, largely on expert testimony grounds. A second wave of federal bellwether trials begins July 6, 2026, followed by August 2026, November 2026, and February 2027. The Missouri defense verdict — previously the only defense win — was overturned for misconduct and a retrial ordered. State court verdicts total over $625 million to date. Individual case values depend on specific facts and venue.
